Form 8-K - Current report:
SEC Accession No. 0001193125-24-196457
Filing Date
2024-08-08
Accepted
2024-08-08 07:00:29
Documents
13
Period of Report
2024-08-08
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d792052d8k.htm   iXBRL 8-K 22023
  Complete submission text file 0001193125-24-196457.txt   143005

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA grtx-20240808.xsd EX-101.SCH 2511
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE grtx-20240808_lab.xml EX-101.LAB 17946
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grtx-20240808_pre.xml EX-101.PRE 11235
16 EXTRACTED XBRL INSTANCE DOCUMENT d792052d8k_htm.xml XML 3754
Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

EIN.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39114 | Film No.: 241185941
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)